You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This second edition of a very successful book is thoroughly updated with existing chapters completely rewritten while the content has more than doubled from 16 to 36 chapters. As with the first edition, the focus is on industrial pharmaceutical research, written by a team of industry experts from around the world, while quality and safety management, drug approval and regulation, patenting issues, and biotechnology fundamentals are also covered. In addition, this new edition now not only includes biotech drug development but also the use of biopharmaceuticals in diagnostics and vaccinations. With a foreword by Robert Langer, Kenneth J Germeshausen Professor of Chemical and Biomedical Engineering at MIT and member of the National Academy of Engineering and the National Academy of Sciences.
This readily comprehensible book explains the identification of molecular targets via cellular assays, reporter genes or transgenic models, as well as surveying recent advances in the synthesis, separation and analysis of drugs. A special section is devoted to molecular genetics methods. With its examination of these novel methods and generous practical advice, this is essential reading for all pharmaceutical chemists, molecular biologists and medical researchers using molecular methods to study drugs and their action.
Concepts of nonlinear physics are applied to an increasing number of research disciplines. With this volume, the editors offer a selection of articles on nonlinear topics in progress, ranging from physics and chemistry to biology and some applications of social science. The book covers quantum optics, electron crystallization, cellular or flow patterns in fluids and in granular media, biological systems, and the control of brain structures via neuronal excitation. Chemical patterns are looked at both in bulk solutions and on surfaces in heterogeneous systems. From regular structures, the authors turn to the more complex behavior in biology and physics, such as hydrodynamical turbulence, low-dimensional dynamics in solid-state physics, and gravity.
This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master’s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.
EduGorilla Publication is a trusted name in the education sector, committed to empowering learners with high-quality study materials and resources. Specializing in competitive exams and academic support, EduGorilla provides comprehensive and well-structured content tailored to meet the needs of students across various streams and levels.
Novel Phytopharmaceutical for Management of Disorders covers recent advances surrounding phytopharmaceuticals and their potential uses in the management of several disorders as well as in cosmetic benefits. Sections cover the concepts of phytopharmaceuticals and current highlights in disease management. This book also emphasizes phytopharmaceutical drug delivery studies in vivo–in vitro study to various target organs like lungs, liver, and brain. This book provides key information for everyone interested in disease management, drug discovery, and delivery, including medicinal chemists, cosmetic experts, nutritionists, toxicologists, drug formulators, and health care professionals. Students...
Das neue Lehrbuch der Pharmazeutischen Biologie mit seinen Lehrinhalten für den zweiten Prüfungsabschnitt informiert über drei große Themenkreise biogener Arzneimittel: über pflanzliche Arzneimittel der besonderen Therapierichtungen mit Schwerpunkt Phytotherapie, über Arzneimittel aus Mikroorganismen, speziell über Antibiotika und Immuntherapeutika und über die neue Palette an Wirkstoffen, die gentechnisch hergestellt werden. Die Stoffinhalte umfassen traditionelle Arzneimittel und biotechnologisch entwickelte Wirkstoffe gleichermaßen. Die Arzneimittel der besonderen Therapierichtungen werden aus der Sicht der naturwissenschaftlich orientierten Medizin dargestellt. Die Stoffgebiete werden fächerübergreifend abgehandelt; dabei ist die Verbindung zur Pharmakologie besonders eng. Erstmalig in einem Lehrbuch werden wissenschaftlich begründete Aussagen paramedizinischen Aussagen kritisch gegenüber gestellt: besonders hierin liegt der Praxisbezug des Buches für den Apotheker.
None
In industrialisierten Ländern ist der Einsatz synthetischer Pharmaka für die Diagnose und Therapie von Krankheiten, für das Wohlbefinden der Bevölkerung und für die Fertilitätskontrolle zum festen Bestandteil des Alltags geworden. Der Verbleib dieser Teils hochwirksamen Stoffe nach ihrer Zweckanwendung sowie die Entsorgung ungebrauchter Produkte sind wichtige Fragen, die unmittelbar aus der Befürchtung möglicher Auswirkungen auf die Umwelt erwachsen. Unter dem Titel "Heillasten", der die ambivalente Rolle der Pharmaka widerspiegelt, will dieses Buch eine Standortbestimmung zu diesem aktuellen Problembereich vornehmen und Wege aufzeigen, wie man zukunftsgerichtet mit ihm umgeht. Dies geschieht transdisziplinär aus den Blickwinkeln der Entwicklung und Verwendung der Produkte, der Medizin, des rechtlichen Umweltschutzes, der Gewässerökologie und der Wassertechnik. Der angestoßene Diskurs auf der Basis belastbarer Fakten und fachkundiger Einschätzungen soll helfen, den aktuellen Informationsstand und weiteren Forschungsbedarf aufzuzeigen.